News

FDA delays approval decision for Bayer menopause therapy
The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and the U.K. have already cleared it for use.
WSKG13h
Doctors urge FDA to remove black box warning on hormone therapy for menopause
The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...
Bayer's Elinzanetant review period gets extended by FDA
Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) (OTCPK:BAMXF) said it has received notification from the FDA regarding an extension of the ...
Her Agenda on MSN17h
F.D.A. Discusses Removal Of Most Severe Warning On Menopause Treatments
At a recent U.S. Food and Drug Administration (F.D.A.) panel, doctors argued for the removal of the black box warning on ...
Iowa Public Radio19h
Warning labels on menopause treatments 'scare women,' doctors tell the FDA
The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...